枢纽中断的增加与自体主导性阿尔茨海默氏症中痴呆症严重程度的并行
Jiaxin Cindy Tu1, Peter R Millar2, Jeremy F Strain2
1Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Network neuroscience (Cambridge, Mass.)
|December 30, 2024
概括
在阿尔茨海默病 (AD) 易受伤害的大脑中心区域显示有针对性的干扰,而不是随机的. 这种临床前AD大脑网络变化在12年之前出现症状,支持活动依赖性退化.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医疗成像医学成像
背景情况:
- 大脑中心区域对于信息传输至关重要,但在像阿尔茨海默氏症 (AD) 这样的神经退行性疾病中是脆弱的.
- 活动依赖性退化是核心漏洞的一个建议机制,但人类证据和与随机攻击的区别是有限的.
研究的目的:
- 调查在自体主导AD中功能性大脑连接中的枢纽干扰模式.
- 区分针对性和随机攻击对AD大脑网络之间的区别.
- 探索枢纽中断与疾病进展和生物标志物的时间和关系.
主要方法:
- 改进了枢纽中断指数的改进.
- 在自体主导AD.功能连接的分析.
- 与粉样β定子发射断层扫描 (PET) 标记物的相关性.
主要成果:
- 一个与有针对性的攻击相一致的枢纽干扰模式在自体主导AD中被确定.
- 枢纽干扰在症状出现12年前就能被检测出来,并且随着进展而恶化.
- 干扰与全球连接相关,并遵循粉样β-PET变化,支持活动依赖性退化.
结论:
- 在AD中大脑网络的破坏表现出有针对性的攻击模式,而不是随机的.
- 阿尔茨海默病中的枢纽脆弱性与活动依赖性退化有关,并且可以在早期检测到.
- 这些发现可能有助于制定AD的诊断和治疗策略.
相关概念视频
Alzheimer's Disease: Overview
311
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
311
Dementia
63
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
63
Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
Neural Regulation
38.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
38.9K
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Disorders of the Nervous Tissue
926
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
926


